Recruiting studies: Cisplatin Nephrotoxicity

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Cisplatin Induced Kidney Toxicity
Phase N/A · 1 location(s) · The Hospital for Sick Children · NCT04442516 The Nephroprotective Effect of Metformin With Cisplatin in Bladder Cancer
Phase 4 · 1 location(s) · Cairo University · NCT06215976 Protecting the Kidney's Proximal Tubules From Platinum-Based Chemotherapy Toxicity
Phase 2 · 1 location(s) · Instituto Nacional de Ciencias Medicas y Nutricion Salvador · NCT07018622 L-Carnitine Protective Effect in Nephrotoxicity
Phase 2 · 1 location(s) · Tanta University · NCT07108777 Pantoprazole in Cisplatin Nephrotoxicity
Phase 3 · 1 location(s) · Sherief Abd-Elsalam · NCT04217512 Treatment of Radiation and Cisplatin Induced Toxicities with Tempol
Phase 2 · 9 location(s) · Matrix Biomed, Inc. · NCT03480971 Alpha-Lipoic Acid in Mitigating Cisplatin-Induced Nephrotoxicity
Phase 2 · 1 location(s) · Minia University · NCT07564479

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.